ASYMMETRIC SUBSTITUTED TETRAPYRROLE COMPOUND, PROCESS OF PREPARATION AND BIOLOGICAL EVALUATION THEREOF AT CELLULAR LEVEL

ASYMMETRIC SUBSTITUTED TETRAPYRROLE COMPOUND, PROCESS OF PREPARATION AND BIOLOGICAL EVALUATION THEREOF AT CELLULAR LEVEL

The invention relates to an asymmetric substituted tetrapyrrole compound, to a process for preparing the same and to the use thereof as an active substance in pharmaceutical forms intended to be employed in antitumour therapy. According to the invention, the compound is 5-[(3,4-methylene-dioxy)pheny...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: NEAGU MONICA, BOSCENCU RICA, ILIE MIHAELA, LUIS FELIPE VIEIRA FERREIRA, MANDA GINA, SOCOTEANU RADU PETRE, ANABELA SOUSA OLIVEIRA, NACEA VERONICA, BACONI DANIELA LUIZA, CONSTANTIN CAROLINA
Format: Patent
Sprache:eng ; rum
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The invention relates to an asymmetric substituted tetrapyrrole compound, to a process for preparing the same and to the use thereof as an active substance in pharmaceutical forms intended to be employed in antitumour therapy. According to the invention, the compound is 5-[(3,4-methylene-dioxy)phenyl]-10,15,20-tris-(4-carboxymethylphenyl)-21,23H porphine. Invenţia se referă la un compus tetrapirolic nesimetric substituit, la un procedeu de obţinere a acestuia şi la utilizarea lui ca substanţă activă, în forme farmaceutice utilizate în terapia antitumorală. Compusul conform invenţiei este 5-[(3,4-metilendioxi)fenil]-10,15,20--(4-carboximetilfenil)-21,23H porfină.